Clinical trial

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

NCT03998657

Study summary

ClinicalTrials.gov

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Exablate Prostate Treatment Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-12-19

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Exablate Prostate TreatmentDEVICE

Sponsors & collaborators

InSighteclead sponsor

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1 RochesterMinnesota, United States1 StanfordCalifornia, United States1 Delray BeachFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03998657 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.